While FBG is essential for assessing insulin resistance and hs-CRP is useful for measuring systemic inflammation, neither captures the intricate relationship between lipid metabolism and atherosclerotic risk as well as AIP. This evidence concerns the gene MAP3K14 and Insulin resistance.